NCT05318768

Brief Summary

In this study, it is assumed that grip strength is associated with pelvic floor muscle strength. And the outcome of pelvic floor function can be predicted by referring to the status of pelvic floor muscle strength through the value of grip strength, which is labor-saving, time-saving and more convenient for evaluating pelvic floor muscle function. Moderate physical activity and increase the overall strength can activate the potential mechanism of pelvic floor muscle contraction at the same time may be a "core muscles" overall effect, that core muscles mainly includes transverse abdominal muscle, pelvic floor muscles and the muscles around the back, these muscles in the body movement to spontaneous collaboration contract pelvic floor muscles, enhancing pelvic floor muscle function, thus reducing the incidence of pelvic floor dysfunction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
929

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2021

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 8, 2022

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

February 6, 2023

Status Verified

February 1, 2023

Enrollment Period

29 days

First QC Date

March 23, 2022

Last Update Submit

February 2, 2023

Conditions

Keywords

womenphysical activityoverall muscle strengthhand grip strengthpelvic floor muscle strength

Outcome Measures

Primary Outcomes (5)

  • Pelvic floor muscle strength grading

    The result was recorded using the modified Oxford Grading scale, ranging from 0 to 5, which 0 represents no discernible pelvic floor muscle contraction and 5 represents a strong pelvic floor muscle contraction.

    through study completion,an average of one day

  • Overall body strength measured by hand grip strength

    Grip strength index is used to evaluate adult muscle strength in Chinese National Physical Fitness Standards. Grip strength is an important indicator to evaluate an individual's upper limb strength and can reflect the overall muscle strength level which was used to evaluate the overall strength of participants.

    through study completion,an average of one day

  • Physical activity levels

    International Physical Activity Questionnaire score- short from is used to measure the overall physical activity level. Paticipants volunteered for the study and filled out questionnaires to rate their levels of physical activity over the past week which can represent the overall physical activity level.

    through study completion, an average of the past one week

  • Pelvic Floor Distress Inventory#PFDI-20#Questionnaire Score

    The Pelvic Floor Distress Inventory Questionnaire-20 (PFDI-20) is the short-form version of the Pelvic Floor Distress Inventory (PFDI).Since it is comprised of the UDI-6, POPDI-6, and the CRADI-8, the PFDI-20 includes 20 questions.The scale scores are found individually by calculating the mean value of their corresponding questions and then multiplying by 25 to obtain a value that ranges from 0 to 100.The sum of the 3 scales are added together to get the PFDI-20 summary score, which ranges from 0 to 300.

    through study completion, an average of the past 3 months

  • FSFI-6 Questionnaire Score

    The 6-item Female Sexual Function Index (FSFI) is a short form of the original 19-item FSFI that measures sexual function in women.It comprises six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. Desire and satisfaction items are rated on a 5-point Likert scale, ranging from 1 to 5, and the other items are rated on a 6-point Likert scale, ranging from 0 to 5. Total scores range from 2 to 30, with lower scores indicating worse sexual functioning.

    through study completion, an average of the past four weeks

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study is a cross-sectional observational study, planned to enroll 1143 participants from Gynecology Outpatient Clinic. PASS.15 software was used for sample size calculation. α- error level was set as 0.05, U0.05=1.96. For the main indicators, according to the epidemiological investigation of FEMALE PFD by our previous study, the comprehensive selection of PFD prevalence is 10%, and error δ=4%, calculated n=914, proposed to increase the loss rate by 20%. The sample size was about 1143.

You may qualify if:

  • Gynecological outpatient clinic patients
  • In good condition and able to actively cooperate
  • Agree to conduct the study.
  • Age range: 18 to 80 years old

You may not qualify if:

  • Patients who has a history of pelvic surgery or has had pelvic floor functional diseases
  • Patients who do not have sex
  • Pregnancy
  • Patients who have serious medical diseases
  • Patients with cardiac dysfunction or wear pacemakers
  • Patients with neurological diseases and cognitive impairment who are difficult to cooperate with the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Peoples Hospital

Beijing, Beijing Municipality, 10000, China

Location

MeSH Terms

Conditions

Pelvic Floor DisordersMotor Activity

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital DiseasesBehavior

Study Officials

  • Xiuli Sun, PHD

    Study Chair

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

March 23, 2022

First Posted

April 8, 2022

Study Start

October 1, 2021

Primary Completion

October 30, 2021

Study Completion

April 30, 2022

Last Updated

February 6, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share

1. Date of disclosure of raw data: December 2023. Data content: original recorded data and research proposals; 2. Ways or means of sharing IPDs, contact the researchers.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
2years
Access Criteria
contact the researchers

Locations